Similar to other studies where subject enrichment helped elucidate specific subgroups who may respond to particular antidepressant interventions (e.g., elevated CRP in studies of inflammation and depression) [38], administering anti-inflammatory treatment interventions to MDD subjects selected for increased TSPO binding may be key to future studies. The gene discussed is CRP; the disease is depressive disorder.